Absorption: Actively absorbed after oral administration by a saturable process. IV administration results in complete bioavailability.
Distribution: Widely distributed. Crosses the placenta; enters breast milk.
Metabolism/Excretion: Converted to compounds that are excreted by the kidneys.
Half-life: 7.4 hr.
(response to skeletal and hemorrhagic changes in scurvy)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO, IM, IV, SUBQ | 2 days3 wk | unknown | unknown |
Contraindicated in:
Use Cautiously in:
Derm: flushing.
GI: vomiting, cramps, diarrhea, heartburn, nausea.
GU: nephrolithiasis, oxalate nephropathy.
Hemat: hemolysis (in G6PD deficiency), deep vein thrombosis.
Local: pain at SUBQ, IM, or IV sites.
Drug-Drug:
(Generic available)
IV Administration:
Ascor, Ascorbicap, Cebid, Cecon, Cecore-500, Cemill, Cenolate, Cetane, Cevalin, Cevi-Bid, Flavorcee, Mega-C/A Plus, Ortho/CS, Sunkist